China Animal Husbandry Industry (XSSC:600195) Stock Valuation, Peer Comparison & Price Targets

Q: What is the Fair Price of 600195 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

600195 (CN¥6.98) is trading above our estimate of [[fair value]] (CN¥2.43)

Share Price vs Fair Value

What is the Fair Price of 600195 when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: 600195 (CN¥6.98) is trading above our estimate of fair value (CN¥2.43)

Significantly Below Fair Value: 600195 is trading above our estimate of fair value.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for 600195?

Key metric: As 600195 is profitable we use its Price-To-Earnings Ratio for relative valuation analysis.

The above table shows the Price to Earnings ratio for 600195. This is calculated by dividing 600195's market cap by their current earnings.
What is 600195's PE Ratio?
PE Ratio	81.1x
Earnings	CN¥87.90m
Market Cap	CN¥7.13b

600195 key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenue	1.6x
Enterprise Value/EBITDA	27.3x
PEG Ratio	1.3x

Price to Earnings Ratio vs Peers

How does 600195's PE Ratio compare to its peers?

The above table shows the PE ratio for 600195 vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
Company	Forward PE	Estimated Growth	Market Cap
Peer Average	25.5x
002390 Guizhou Xinbang Pharmaceutical	33.6x	n/a	CN¥7.4b
000597 Northeast Pharmaceutical Group	21.6x	n/a	CN¥7.4b
002349 Jinghua Pharmaceutical Group	32.2x	n/a	CN¥6.7b
601089 Beijing Foyou PharmaLTD	14.8x	n/a	CN¥7.4b
600195 China Animal Husbandry Industry	81.1x	61.5%	CN¥7.1b

Price-To-Earnings vs Peers: 600195 is expensive based on its Price-To-Earnings Ratio (81.1x) compared to the peer average (25.2x).

Price to Earnings Ratio vs Industry

How does 600195's PE Ratio compare vs other companies in the CN Pharmaceuticals Industry?

0 Companies	Price / Earnings	Estimated Growth	Market Cap

No more companies available in this PE range

0 Companies		Estimated Growth	Market Cap

No more companies

Price-To-Earnings vs Industry: 600195 is expensive based on its Price-To-Earnings Ratio (81.1x) compared to the CN Pharmaceuticals industry average (29.9x).

Price to Earnings Ratio vs Fair Ratio

What is 600195's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

600195 PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio	81.1x
Fair PE Ratio	48.3x

Price-To-Earnings vs Fair Ratio: 600195 is expensive based on its Price-To-Earnings Ratio (81.1x) compared to the estimated Fair Price-To-Earnings Ratio (48.3x).

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst 600195 forecast and predictions for the stock price in 12 month’s time.
Date	Share Price	Average 1Y Price Target	Dispersion	High	Low	1Y Actual price	Analysts
Current	CN¥6.98	CN¥8.75 +25.4%	22.1%	CN¥12.00	CN¥7.10	n/a	4
Nov ’25	CN¥6.82	CN¥8.86 +29.9%	19.7%	CN¥12.00	CN¥7.10	n/a	5
Oct ’25	CN¥7.23	CN¥8.74 +20.9%	20.5%	CN¥12.00	CN¥7.10	n/a	5
Sep ’25	CN¥6.13	CN¥8.74 +42.6%	20.5%	CN¥12.00	CN¥7.10	n/a	5
Aug ’25	CN¥6.60	CN¥10.48 +58.8%	19.2%	CN¥12.50	CN¥7.10	n/a	5
Jul ’25	CN¥7.65	CN¥11.30 +47.7%	15.7%	CN¥13.80	CN¥8.70	n/a	6
Jun ’25	CN¥8.77	CN¥11.62 +32.5%	14.9%	CN¥13.80	CN¥9.30	n/a	6
May ’25	CN¥8.82	CN¥11.62 +31.7%	14.9%	CN¥13.80	CN¥9.30	n/a	6
Apr ’25	CN¥9.73	CN¥13.72 +41.0%	22.6%	CN¥18.90	CN¥9.60	n/a	6
Mar ’25	CN¥9.54	CN¥14.20 +48.8%	17.9%	CN¥18.90	CN¥11.50	n/a	6
Feb ’25	CN¥9.02	CN¥14.20 +57.4%	17.9%	CN¥18.90	CN¥11.50	n/a	6
Jan ’25	CN¥11.86	CN¥14.20 +19.7%	17.9%	CN¥18.90	CN¥11.50	n/a	6
Dec ’24	CN¥11.47	CN¥14.20 +23.8%	17.9%	CN¥18.90	CN¥11.50	n/a	6
Nov ’24	CN¥11.14	CN¥14.38 +29.1%	16.5%	CN¥18.90	CN¥11.50	CN¥6.82	6
Oct ’24	CN¥11.29	CN¥14.50 +28.4%	16.2%	CN¥18.90	CN¥11.50	CN¥7.23	6
Sep ’24	CN¥11.64	CN¥14.38 +23.6%	17.5%	CN¥18.90	CN¥10.80	CN¥6.13	6
Aug ’24	CN¥12.23	CN¥15.55 +27.1%	18.7%	CN¥18.90	CN¥10.80	CN¥6.60	6
Jul ’24	CN¥11.68	CN¥15.55 +33.1%	18.7%	CN¥18.90	CN¥10.80	CN¥7.65	6
Jun ’24	CN¥12.37	CN¥15.82 +27.9%	17.0%	CN¥18.90	CN¥10.80	CN¥8.77	6
May ’24	CN¥13.00	CN¥16.93 +30.3%	8.9%	CN¥18.90	CN¥14.20	CN¥8.82	6
Apr ’24	CN¥14.92	CN¥17.96 +20.4%	14.9%	CN¥23.00	CN¥14.20	CN¥9.73	6
Mar ’24	CN¥15.76	CN¥17.62 +11.8%	16.4%	CN¥23.00	CN¥14.20	CN¥9.54	6
Feb ’24	CN¥14.14	CN¥16.55 +17.0%	10.7%	CN¥19.14	CN¥14.20	CN¥9.02	5
Jan ’24	CN¥11.62	CN¥16.46 +41.7%	12.0%	CN¥19.14	CN¥14.20	CN¥11.86	4
Dec ’23	CN¥13.49	CN¥16.46 +22.0%	12.0%	CN¥19.14	CN¥14.20	CN¥11.47	4
Nov ’23	CN¥13.66	CN¥16.11 +17.9%	15.0%	CN¥19.14	CN¥12.80	CN¥11.14	4

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.

Discover undervalued companies

Sichuan Kelun Pharmaceutical

CN¥49.3b

Researches, develops, manufactures, distributes, and sells pharmaceutical products in China.

2422

CN¥32.66

7D

2.6%

1Y

14.2%

Dong-E-E-JiaoLtd

CN¥36.7b

Research and development, production, and sale of Ejiao and a series of Chinese patent medicines, health foods, and foods.

423

CN¥58.18

7D

-0.4%

1Y

15.5%

China Resources Double-Crane PharmaceuticalLtd

CN¥21.2b

China Resources Double-Crane Pharmaceutical Co.,Ltd.

600062

CN¥21.11

7D

-5.1%

1Y

14.5%

China Animal Husbandry Industry Valuation